• 제목/요약/키워드: AI Vaccine

검색결과 14건 처리시간 0.023초

SPF 닭에서 재조합 H9N3 조류 인플루엔자 백신의 효능과 안전성 평가

  • 신정화;모인필
    • 한국가금학회:학술대회논문집
    • /
    • 한국가금학회 2006년도 제23차 정기총회 및 학술발표회
    • /
    • pp.90-91
    • /
    • 2006
  • To reduce the economic impact and control Low pathogenic avian influenza (LPAI), vaccination with inactivated vaccine has been considered in this country. We tried to develop inactivated vaccine with reassorted H9N3 AI virus which has different type of neuraminidase compare to those of field AI virus. Before reassorted vaccine was produced, we confirm the virus as master seed by limiting dilution, RT-PCR and sequencing method. Also, we evaluate the biological characteristics of the virus to find out the possibility of prevention against field infection of AI virus. Finally, we evaluate the safety and efficacy of the vaccine made of reassorted AI virus in the specific pathogen free (SPF) chickens. After limiting dilution, we choose RV7CE4 as a vaccine candidate and compare the gene sequence of this vaccine strain to those of AI05GA which is parents strain. Compared to amino acid sequences of specific gene of AI05GA and RV7CE4, exhibited a high degree of amino acid sequence homology. In the safety and efficacy test, there were no specific clinical signs or mortality. Reassorted H9N3 viruses were reisolated in cloaca swab on 5 days post inoculation. In the vaccine study, once or twice vaccination was performed and challenged with H9N2 field virus (01310). Vaccine has no adverse effect on birds and formed good immune capability which reduce viral shedding in the birds infected with 01310. Based on the above result, we developed reassorted H9N3 vaccine which will efficiently prevent the low pathogenic AIV (H9N2) infection in the poultry farms.

  • PDF

Modulation of Humoral and Cell-Mediated Immunity Against Avian Influenza and Newcastle Disease Vaccines by Oral Administration of Salmonella enterica Serovar Typhimurium Expressing Chicken Interleukin-18

  • Rahman, Md Masudur;Uyangaa, Erdenebileg;Eo, Seong Kug
    • IMMUNE NETWORK
    • /
    • 제13권1호
    • /
    • pp.34-41
    • /
    • 2013
  • Interleukin-18 (IL-18) has been known to induce interferon-${\gamma}$ (IFN-${\gamma}$) production and promote Th1 immunity. Although mammalian IL-18 has been characterized in great detail, the properties and application of chicken IL-18 remain largely uninvestigated as of yet. In this study, we evaluated the immunomodulatory properties of Salmonella enterica serovar Typhimurium expressing chicken interleukin-18 (chIL-18) on immune responses induced by avian influenza (AI) and Newcastle disease (ND) vaccines. After oral administration of S. enterica serovar Typhimurium expressing chIL-18, chickens were vaccinated intramuscularly with the recommended dose of either inactivated AI H9N2 vaccine or ND (B1 strain) vaccine. Chickens receiving a primary vaccination were boosted using the same protocol 7 days later. Humoral and cell-mediated immune responses were evaluated in terms of HI antibody titers and proliferation and mRNA expression of IFN-${\gamma}$ and IL-4 of peripheral blood mononuclear cells (PBMC) in response to specific antigen stimulation. According to our results, oral administration of S. enterica serovar Typhimurium expressing chIL-18 induced enhanced humoral and Th1-biased cell-mediated immunity against AI and ND vaccines, compared to that of chickens received S. enterica serovar Typhimurium harboring empty vector. Therefore, we conclude that our proposed vaccination regimen using inactivated AI and ND viruses along with oral administration of S. enterica serovar Typhimurium expressing chIL-18 may provide a novel approach in protecting chicken from currently circulating AI and ND virus strains.

약병원성 조류인플루엔자 사독백신개발을 위한 후보주(ADL0401)의 면역 원성 및 안전성 평가 (Evaluation on Immunogenicity and Safety of Avian Influenza Isolate(ADL0401) as a Candidate for the Killed Vaccine against tow-Pathogenic Avian Influenza)

  • 이진성;하대희;김정은;하봉도;모인필
    • 한국가금학회지
    • /
    • 제32권2호
    • /
    • pp.113-123
    • /
    • 2005
  • 본 연구는 약병원성 조류인플루엔자 사독백신 개발을 위하여 백신 후보주(ADL0401)로서의 생물학적 특성 및 개발 백신에 대한 면역원성 및 안전성 평가를 실시하였다. 백신 후보주인 ADL0401의 병원성을 조사한 결과 폐사는 없었으며, 임상증상 및 바이러스 재분리율 양상이 국내 표준 야외주인 MS96과 상당히 유사한 생물학적 특성을 나타내어 약병원성 조류인플루엔자의 특징을 갖고 있음을 알 수 있었다. 표준야외주인 MS96과 백신후보주인 ADL0401간의 이종항원의 중화능 실험을 한 결과 r값 = 0.71로 동종항원(r값 = 1)에 비하여 다소 낮은 중화능을 나타내었지만, 두 바이러스간의 항원성엔 큰 차이가 없음을 알 수 있었다. 불활화 능력실험으로 $0.1\%$ Formalin을 $37^{\circ}C$ 조건에서 처리하였을 때 가장 효과적인 결과를 가져왔으며, MS96은 2시간, ADL0401은 1시간만에 다소의 역가 저하는 있었으나 빠르게 불활화가 이루어짐을 확인하였다. 개발 백신의 면역원성 및 안전성 실험 결과 ISA 70 adjuvant 백신 접종시 백신 접종 전후로 폐사율 및 임상증상은 관찰되지 않았으며, 높은 수준의 항체 역가를 형성함으로써 가장 면역원성이 우수한 것으로 확인되었다.

적대적 공격의 방어를 위한 AI 백신 연구 (A Study on AI Vaccine for the Defense against Adversarial Attack)

  • 송채원;오승아;정다예;임유리;노은지;이규영
    • 한국정보처리학회:학술대회논문집
    • /
    • 한국정보처리학회 2021년도 추계학술발표대회
    • /
    • pp.1132-1135
    • /
    • 2021
  • 본 논문에서는 머신러닝 시스템에 심각한 오류를 발생시킬 수 있는 적대적 샘플을 제작하고, 이를 이용한 적대적 공격을 효과적으로 예방하고 방어할 수 있는 Adversarial Training 기반의 AI 백신을 개발하였으며, 본 논문이 제안하는 AI 백신이 적대적 샘플을 올바르게 인식하고 AI 공격 성공율을 현저하게 낮추는 등 강인성을 확보한 것을 실험을 통해 입증하였다. 아울러 스마트폰을 통해 수행결과를 확인할 수 있는 어플리케이션을 구현하여, 교육 및 시연 등을 통해 적대적 AI 공격에 대한 심각성을 인식하고 해당 방어과정을 명확히 이해할 수 있도록 하였다.

Current situation and control strategies of H9N2 avian influenza in South Korea

  • Mingeun Sagong;Kwang-Nyeong Lee;Eun-Kyoung Lee;Hyunmi Kang;Young Ki Choi;Youn-Jeong Lee
    • Journal of Veterinary Science
    • /
    • 제24권1호
    • /
    • pp.5.1-5.16
    • /
    • 2023
  • The H9N2 avian influenza (AI) has become endemic in poultry in many countries since the 1990s, which has caused considerable economic losses in the poultry industry. Considering the long history of the low pathogenicity H9N2 AI in many countries, once H9N2 AI is introduced, it is more difficult to eradicate than high pathogenicity AI. Various preventive measures and strategies, including vaccination and active national surveillance, have been used to control the Y439 lineage of H9N2 AI in South Korea, but it took a long time for the H9N2 virus to disappear from the fields. By contrast, the novel Y280 lineage of H9N2 AI was introduced in June 2020 and has spread nationwide. This study reviews the history, genetic and pathogenic characteristics, and control strategies for Korean H9N2 AI. This review may provide some clues for establishing control strategies for endemic AIV and a newly introduced Y280 lineage of H9N2 AI in South Korea.

돼지 전염성 위장염 바이러스(국내분리주)의 분자생물학적 특성 규명 (Molecular biological characterization of transmissible gastroenteritis viruses isolated in Korea)

  • 권혁무;피재호
    • 대한수의학회지
    • /
    • 제38권2호
    • /
    • pp.304-313
    • /
    • 1998
  • Sixteen Korean field transmissible gastroenteritis viruses (TGEVs) were isolated using swine testicular cell (STC) and the genomic diversity of them was analyzed. All TGEV isolates produced a typical cytopathic effect in STC and were confirmed as TGEV by immunofluorescence assay using monoclonal antibody against TGEV and PCR using TGEV specific primers. RNAs from TGEV field isolates and vaccine TGEV were extracted and amplified by RT and PCR. The RT-PCR products were digested with selected restriction enzymes and analyzed RFLP patterns. The N-terminal end region of S gene and ORF 3 and 3-1 genes of TGEV amplified by TGEV specific primer pairs seemed to be conserved. Most specific variations were detected in S gene amplified by TGEV 4/6 primer pairs which includes antigenic sites A and D. When the PCR products were treated with Sau3AI and Ssp I, Bvac(vaccine strain), field isolates 133 and 347 were differentiated from Miller and Purdue types. In the case of D5 field isolates, it was classified into Purdue type by Sau 3AI but classified into independent TGEV by Ssp I. Two different TGEV strains from D2 sample were confirmed by plaque purification and RT-PCR-RFLP analysis. To investigate the change occurring in TGEV genome after serial passage, the TGEV P44 strain was passaged through STC. There were specific changes in S gene and a large deletion was observed in ORF 3 and 3-1 genes. These studies showed that a distinct difference in genome exists among TGEV field isolates.

  • PDF

OP Code 특징 기반의 텍스트와 이미지 데이터셋 연구를 통한 인공지능 백신 개발 (Development of Vaccine with Artificial Intelligence: By Analyzing OP Code Features Based on Text and Image Dataset)

  • 최효경;이세은;이주현;홍래영;최원혁;김형종
    • 정보보호학회논문지
    • /
    • 제29권5호
    • /
    • pp.1019-1026
    • /
    • 2019
  • 지속적으로 새롭게 등장하는 악성 파일(malware)탐지의 어려움으로 인해 머신러닝 기반 인공지능 백신 개발의 중요성이 크게 대두되고 있다. 하지만 현존하는 인공지능 백신은 파일의 일부 영역만을 검사하기 때문에 탐지율이 떨어진다는 단점이 존재한다. 이에 본 논문에서는 독자적인 로직을 기반으로 개발한 인공지능 백신에 근거하여, 파일 내 전체 데이터를 검사하는 방법을 제안한다. 그 중 정상 파일과 비교했을 때 악성 파일에만 존재하는 unique한 함수에서 추출한 OP Code 특징을 학습 데이터셋으로 한 진단법 강화 방안을 제시한다. 해당 강화법의 성능을 Random Forest 알고리즘을 기반으로 한 CSV 데이터셋 학습과 Inception V3 모델을 기반으로 한 이미지 데이터셋 학습으로 나누어 테스트해본 결과, 약 80%의 탐지율을 도출하는 것을 확인할 수 있었다.

SC20를 통해 본 HPC 기술 동향 (HPC Technology Through SC20)

  • 어익수;모희숙;박유미;한우종
    • 전자통신동향분석
    • /
    • 제36권3호
    • /
    • pp.133-144
    • /
    • 2021
  • High-performance computing (HPC) is the underpinning for many of today's most exciting new research areas, to name a few, from big science to new ways of fighting the disease, to artificial intelligence (AI), to big data analytics, to quantum computing. This report captures the summary of a 9-day program of presentations, keynotes, and workshops at the SC20 conference, one of the most prominent events on sharing ideas and results in HPC technology R&D. Because of the exceptional situation caused by COVID-19, the conference was held entirely online from 11/9 to 11/19 2020, and interestingly caught more attention on using HPC to make a breakthrough in the area of vaccine and cure for COVID-19. The program brought together 103 papers from 21 countries, along with 163 presentations in 24 workshop sessions. The event has covered several key areas in HPC technology, including new memory hierarchy and interconnects for different accelerators, evaluation of parallel programming models, as well as simulation and modeling in traditional science applications. Notably, there was increasing interest in AI and Big Data analytics as well. With this summary of the recent HPC trend readers may find useful information to guide the R&D directions for challenging new technologies and applications in the area of HPC.

PCR과 RFLP분석을 이용한 transmissible gastroenteritis virus의 spike glycoprotein gene과 nonstructural protein gene의 분석 (Analysis of the spike glycoprotein gene and nonstructural protein gene of transmissible gastroenteritis virus using PCR and RFLP analysis)

  • 권혁무
    • 대한수의학회지
    • /
    • 제36권3호
    • /
    • pp.627-633
    • /
    • 1996
  • To analyze the genomic diversity of transmissible gastroenteritis virus (TGEV), the N-terminal half of the spike (S) glycoprotein gene and nonstructural protein gene (open reading frames 3 and 3-1) were amplified by reverse transcriptase reaction and polymerase chain reaction (RT-PCR), and analyzed using restriction fragment length polymorphism (RFLP) patterns of the amplified DNA. In this study, TGEV Miller (M6) and Purdue (P115) strains were used as reference strains, and two vaccine strains (MSV and STC3) and four Korea isolates (P44, VRI-WP, VRI-41, and VRI-48) were analyzed. All TGEV strains were amplified with three TGEV primer pairs. Although there was some exception in RFLP analysis, this method differentiated TGEV strains into following groups : Miller group (M6 and MSV), Purdue group (PUS, STC3, P44, VRI-WP, VRI-41, and VRI-48). Using Sau3AI and SspI, VRI-48 was differentiated from the Miller and Purdue type viruses. The RT/PCR in conjuction with RFLP analysis was a rapid and valuable tool for differentiating several strains of TGEV. This study revealed the occurences of distinct difference in genome of TGEV strains.

  • PDF

면역체 분석을 위한 탄저균 유전자 발현 라이브러리의 구축 (Construction of the Genomic Expression Library of Bacillus anthracis for the Immunomic Analysis)

  • 박문규;정경화;김연희;이기은;채영규;윤장원
    • 미생물학회지
    • /
    • 제46권1호
    • /
    • pp.21-26
    • /
    • 2010
  • 탄저균(Bacillus anthracis)은 탄저(Antrax)의 원인균으로 사람은 물론, 초식동물인 소, 양, 말 등에서 급성의 폐사성 전염병을 일으킨다. 현재 사용되고 있는 탄저 치료 및 예방법은 항생제 치료와 약독화 백신주를 토대로 하고 있으나, 항생제 내성주의 출현 및 잔류 병원성이 문제시 되고 있는 실정이다. 따라서, 인체에 적용 가능하며 보다 안전한 탄저 치료제 및 백신 개발이 요구되고 있으며, 최근 탄저균 아포 및 영양세포, 그리고 탄저독소(Anthrax toxins)에 대한 동시 면역을 유도하는 다가백신 개발이 보고된 바 있다. 본 연구에서는, 향후 탄저균에 대한 새로운 다가백신 후보물질 발굴을 위하여, 탄저균에 대한 전장 유전자 발현 라이브러리(whole genomic expression library)를 구축하였다. 라이브러리 구축을 위하여, 탄저균(ATCC 14578) 게놈 DNA를 Sau3AI으로 부분 제한효소 처리였고, 유도 발현이 가능한 pET30abc 벡터에 접합시킴으로써, 총 $1{\times}10^5$개에 해당하는 대장균 BL21(DE3) 유래의 전장 유전자 발현 라이브러리를 구축하였다. 염기서열분석을 통한 중복성(redundancy) 확인 결과, 111개의 무작위 클론 중 56개(50.5%)가 탄저균 유전자로 확인되었으며, 17개(15.3%)는 벡터 유전자였고, 38개(34.2%)는 BLAST 탐색에서 일치하는 유전자를 찾지 못하였다. 또한 웨스턴 분석을 통하여 단백질 유도발현을 확인하였으며, 탄저균 항혈청에 대한 colony blot으로부터 양성반응을 보이는 일부 클론들을 확인할 수 있었다. 이러한 결과물들은, 구축된 전장 유전자 발현 라이브러리가 향후 탄저균에 대한 면역체(immunome) 분석을 위해 적용 가능함을 암시한다.